Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Nondisjunction01:29

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
Nondisjunction01:29

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

A moonshot for diabetes and obesity.

iGIE : innovation, investigation and insights·2026
Same author

Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma.

Gastro hep advances·2024
Same author

An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva.

Science translational medicine·2024
Same author

Bariatrics and endoscopic therapies for the treatment of metabolic disease: Past, present, and future.

Diabetes research and clinical practice·2024
Same author

Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label, mechanistic, pilot study.

Gastrointestinal endoscopy·2024
Same author

Author Correction: 14-3-3σ is required to prevent mitotic catastrophe after DNA damage.

Nature·2023

Video Experimental Relacionado

Updated: May 8, 2026

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
05:22

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes

Published on: April 13, 2018

Aneuploidía y cáncer.

Harith Rajagopalan1, Christoph Lengauer

  • 1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 Orleans Street, Baltimore, Maryland 21231, USA.

Nature
|November 19, 2004
PubMed
Resumen

Las células cancerosas con frecuencia exhiben aneuploidía, un número cromosómico anormal, a menudo debido a la inestabilidad cromosómica. La comprensión de este proceso puede conducir a nuevas terapias contra el cáncer dirigidas a la aneuploidía.

Área de la Ciencia:

  • Oncología Oncología.
  • Genética La genética.
  • Biología celular Biología celular.

Sus antecedentes:

  • La aneuploidía, caracterizada por números cromosómicos anormales, es un sello distintivo de casi todos los cánceres, que los distingue de las células normales.
  • La evidencia vincula cada vez más la aneuploidía con la inestabilidad cromosómica (IC), una forma de inestabilidad genética.
  • La IC en las células cancerosas puede deberse a errores durante la segregación mitótica, el proceso de separación de los cromosomas.

Objetivo del estudio:

  • Explorar los mecanismos moleculares que subyacen a la aneuploidía en el cáncer.
  • Para investigar la conexión entre la inestabilidad cromosómica y la aneuploidía.
  • Identificar posibles dianas terapéuticas para el tratamiento del cáncer basado en la aneuploidía.

Principales métodos:

Más Videos Relacionados

Manipulation of Ploidy in Caenorhabditis elegans
07:54

Manipulation of Ploidy in Caenorhabditis elegans

Published on: March 15, 2018

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

Videos de Experimentos Relacionados

Last Updated: May 8, 2026

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
05:22

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes

Published on: April 13, 2018

Manipulation of Ploidy in Caenorhabditis elegans
07:54

Manipulation of Ploidy in Caenorhabditis elegans

Published on: March 15, 2018

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

  • Revisión de la literatura existente sobre la aneuploidía y la inestabilidad cromosómica.
  • Análisis de datos genéticos de líneas celulares de cáncer y muestras de pacientes (detalles no proporcionados en resumen).
  • Análisis de la vía molecular para identificar los reguladores clave de la segregación mitótica (detalles no proporcionados en el resumen).

Principales resultados:

  • La aneuploidía es una característica casi universal de las células cancerosas.
  • La inestabilidad cromosómica es un contribuyente significativo al desarrollo de la aneuploidía en el cáncer.
  • Los defectos en la segregación mitótica están implicados como una causa de inestabilidad cromosómica.

Conclusiones:

  • La aneuploidía es una característica crítica del cáncer, que surge de la inestabilidad genética subyacente.
  • Dirigirse a los mecanismos moleculares que causan la aneuploidía presenta una vía prometedora para el desarrollo de nuevos fármacos contra el cáncer.